A comprehensive view of diagnostic tests / monitoring devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Fujifilm Wako Chemicals and Predictive Oncology partner to improve the accuracy of endotoxin testing in biopharmaceuticals; the partnership combines Fujifilm's PYROSTAR bacterial endotoxin detection reagent with Predictive Oncology's EndoPrep technology
Published:
April 25, 2024
by Fujifilm Corp.
|
Labcorp announces 2024 first quarter results
Published:
April 25, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
Labcorp selected as winning bidder for select assets of Invitae, a leading medical genetics firm, pending court approval; deal expected to generate between US$275.0M -US$300.0M annually and close by Q3 2024
Published:
April 25, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
ANGLE partners with AstraZeneca to enhance cancer drug development using DNA damage response assay; companies to adapt ANGLE's existing Parsortix-based assay for identifying micronuclei in circulating tumor cells
Published:
April 24, 2024
by Proactive Investors
|
Roche reports group sales increase by 2% year-over-year due to the success of newer medicines and diagnostics, independent of COVID-19 products; the surge was offset by the strengthening of the Swiss franc and a decline in COVID-19 test demand
Published:
April 24, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Ask us about our Health Care Sector market view